title: [Incidence of peripheral vascular complications in subjects undergoing coronary angioplasty].
abstract: The peripheral vascular complications following cardiac catheterization for interventional procedures are increasing. The aim of our study is to evaluate the importance of the early removal of the arterial sheath in reducing vascular complications. We examined 451 consecutive patients, submitted to percutaneous transluminal coronary angioplasty (PTCA) by femoral approach. In 229 patients (Group A), we removed the arterial sheath 12-14 hours after PTCA; in 222 patients (Group B) the arterial sheath was removed as soon as possible at the end of PTCA. In 31 Group A and 5 Group B patients we performed a coronarographic study after 12-14 hours. In total, 16 patients (11 Group A, 5 Group B) presented vascular complications. None of the risk factors that we have considered was predictive for complications, except that iliacofemoral atherosclerotic disease. In patients undergoing complex procedures we have found a greater amount of vascular complications. The coronarographic control revealed some pathologic lesion (dissection, occlusive thrombus) only in patients with clear ischemic signs or symptoms, both in Group A and B. In our opinion, an early removal of the arterial sheath reduces the incidence of vascular complications and the period of in-hospital stay.
authors.affiliation: Istituto di Cardiologia, Università degli Studi, Pisa.
authors.forename: A S
authors.initials: AS
authors.lastname: Petronio
authors.forename: G
authors.initials: G
authors.lastname: Amoroso
authors.forename: U
authors.initials: U
authors.lastname: Limbruno
authors.forename: R
authors.initials: R
authors.lastname: Baglini
authors.forename: N
authors.initials: N
authors.lastname: Ciabatti
authors.forename: F
authors.initials: F
authors.lastname: Buttitta
authors.forename: A
authors.initials: A
authors.lastname: Balbarini
authors.forename: M
authors.initials: M
authors.lastname: Mariani
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation; D000925:Anticoagulants / Q000008:administration & dosage; D017023:Coronary Angiography; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D012307:Risk Factors
chemical_list: D000925:Anticoagulants; D006493:Heparin